Beta
Back to CLSK.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

CLSK Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In the latest period of Q1'26, CLSK's operating expenses totaled $15.44M USD, entirely driven by SG&A expenses at $15.44M USD, as R&D expenses remained at $0. This marks a moderate increase from the previous quarter's $14.27M USD total, reflecting ongoing administrative cost pressures without any research and development allocation. Over the period from Q2'23 to Q1'26, SG&A expenses exhibited a strong upward trend, rising from $4.33M USD to $15.44M USD with notable acceleration in Q3'25 at $16.57M USD, indicating expanding operational scale or inefficiencies in a stacked bar chart format. R&D expenses showed no activity throughout, suggesting a strategic focus on sales, general, and administrative functions rather than innovation investments, with overall expenses growing approximately 257% amid potential business expansion.